Histologic Comparison of Ablative Techniques for Endometriosis

Part of paid clinical trials in Cincinnati, Ohio.

Sponsor
TriHealth Inc.
Study ID
NCT06414083
Status
Recruiting
Apply to this trial

Conditions

  • Endometriosis
  • Endometriosis Pelvic
  • Endometriosis-related Pain
  • Endometriosis; Peritoneum

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Diathermy — DEVICE
    Diathermy will be used to ablate the randomized sample.
  • CO2 Laser — DEVICE
    CO2 Laser will be used to ablate the randomized sample.
  • Argon Beam Coagulator — DEVICE
    Argon Beam Coagulator will be used to ablate the randomized sample.

Study Details

To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.

Key Dates

Start date
May 9, 2024
Status verified
May 2024
Primary completion
May 9, 2025
Completion
Jun 9, 2025

Study Design

Enrollment
141 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Diathermy
  • Active Comparator: CO2 Laser
  • Active Comparator: Argon Beam Coagulator

Primary Outcome Measure

Positive Histology [ Time Frame: 0 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Good Samaritan HospitalCincinnatiOhio45220
Devin Namaky, MD
[email protected]
513-862-1888

Find similar trials in Cincinnati, OH

By condition
Endometriosis
By specialty
Women's healthFertility
By research site
Good Samaritan Hospital· Cincinnati, OH

Related Studies